organization · 11 records
Global Trade Research Initiative
India prioritizes energy security despite US tariff threat
Finance Minister Nirmala Sitharaman stated that India will prioritize national energy security and practical sourcing needs over potential US tariff risks.
Russia sanctions bill advances in US House, set for final vote
The US House of Representatives advanced the Lindsey O Graham Sanctioning Russia and Iran Act of 2026, which authorizes tariffs on nations trading oil and gas with Russia.
US House passes bill on Russia sanctions, potential tariffs for India, China
The US House of Representatives passed a bill authorizing the President to impose up to 100% tariffs on countries purchasing oil or gas from Russia.
New US sanctions against Russia could hinder Ukraine peace deal
The Kremlin claims that new US sanctions targeting Russia will complicate ongoing efforts to achieve a peace settlement in the Ukraine conflict.
Supreme Court Petition Challenges New MDR Charges on UPI Transactions
A public interest litigation has been filed in the Supreme Court challenging the Indian government's notification imposing a 0.4% Merchant Discount Rate (MDR) on UPI merchant payments exceeding ₹2,000.
MEA monitoring developments of Russia sanctions bill in U.S. Congress
The Ministry of External Affairs of India is monitoring U.S. legislation that could impose tariffs on countries importing Russian oil and gas.
Indian pharmaceutical firms monitor impact of potential US generic drug tariffs
Indian pharmaceutical companies adopt a wait-and-watch approach in response to U.S. President Trump's proposed tariffs on imported generic drugs, which could significantly impact India's pharma exports.
Indian stock markets decline following US tariff proposal on generic drugs
Indian stock markets fell sharply after Donald Trump announced plans to impose tariffs of up to 200% on imported generic drugs, dragging Sensex and Nifty down with pharmaceutical stocks hit hardest.
Trump announces phased tariff increases on imported generic medicines
President Donald Trump announced a phased tariff plan on imported generic medicines that will keep duties at zero for two years before rising to 100% and then 200% to push pharmaceutical production back to the United States, with major implications for Indian drug exporters.
Donald Trump announces plans for high tariffs on imported generic drugs
Donald Trump announced plans to impose up to 200% tariffs on generic drug imports after a two-year zero-tariff period, a move expected to significantly impact India's generic pharmaceutical exports to the United States.
US announces steep tariffs on generic medicine imports starting August 2028
US President Donald Trump announced steep tariffs on imported generic medicines starting August 2028, aiming to onshore pharmaceutical manufacturing.